Trends in Prepregnancy Obesity and Association With Adverse Pregnancy Outcomes in the United States, 2013 to 2018

Michael C Wang1, Priya M Freaney1,2, Amanda M Perak1,3

  • 1Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.

Insights

Prevalence of prepregnancy obesity and related adverse pregnancy outcomes (APOs) increased from 2013-2018, particularly pregnancy-associated hypertension. These trends varied by race/ethnicity, highlighting disparities in maternal cardiometabolic health.

Area of Science:

  • Reproductive Health
  • Maternal-Fetal Medicine
  • Public Health Epidemiology

Background:

  • Rising obesity rates parallel increasing adverse pregnancy outcomes (APOs).
  • Understanding contemporary trends in prepregnancy obesity and APOs is crucial for targeted prevention.
  • Optimizing maternal and offspring cardiometabolic health requires data on obesity-related pregnancy complications.

Purpose of the Study:

  • To quantify trends in prepregnancy obesity prevalence from 2013-2018.
  • To assess associations between prepregnancy obesity and adverse pregnancy outcomes (APOs).
  • To examine racial/ethnic disparities in obesity prevalence and APOs.

Main Methods:

  • Serial, cross-sectional study using National Center for Health Statistics birth certificate data (2013-2018).
  • Analysis included women aged 15-44 with live singleton births, stratified by race/ethnicity.
  • Prevalence of obesity and adjusted odds ratios for APOs were calculated using multivariable logistic regression.

Main Results:

  • Prepregnancy obesity prevalence increased across all racial/ethnic groups studied (2013-2018).
  • Obesity-associated APOs increased, with adjusted odds ratios ranging from 1.27 to 1.94 by 2018.
  • Obesity showed the strongest association with pregnancy-associated hypertension; population attributable fractions for APOs also increased.

Conclusions:

  • Prepregnancy obesity and its associated APO burden have risen, primarily driven by pregnancy-associated hypertension.
  • Significant racial/ethnic variations exist in obesity prevalence and the burden of obesity-related APOs.
  • Findings underscore the need for tailored public health interventions to address disparities in maternal cardiometabolic health.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
741
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
30
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
30